DAZZI, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 148
EU - Europa 84
AS - Asia 67
Continente sconosciuto - Info sul continente non disponibili 1
Totale 300
Nazione #
US - Stati Uniti d'America 147
CN - Cina 38
IE - Irlanda 24
IT - Italia 21
SE - Svezia 19
SG - Singapore 19
DE - Germania 9
FI - Finlandia 6
IN - India 5
TR - Turchia 5
BE - Belgio 3
CA - Canada 1
CZ - Repubblica Ceca 1
EU - Europa 1
GB - Regno Unito 1
Totale 300
Città #
Chandler 28
Dublin 24
Dearborn 18
Santa Clara 16
Singapore 16
Ann Arbor 7
Parma 7
Ashburn 6
Nanjing 6
New York 6
Shanghai 6
Helsinki 5
Izmir 5
Boardman 4
Bremen 4
Princeton 4
Pune 4
Shenyang 4
Beijing 3
Brussels 3
Changsha 3
Jinan 3
Nanchang 3
Wilmington 3
Falkenstein 2
Houston 2
Los Angeles 2
Scottsdale 2
Tianjin 2
Bangalore 1
Borås 1
Chengdu 1
Des Moines 1
Erba 1
Hangzhou 1
Hebei 1
Manchester 1
Moltrasio 1
Monmouth Junction 1
Nanning 1
Redwood City 1
Seattle 1
Toronto 1
Wuhan 1
Totale 213
Nome #
Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 95
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center? 87
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power 70
Italian, multicenter, phase III, randomized study of cisplatin plus etoposide with or without bevacizumab as first-line treatment in extensive-disease small-cell lung cancer: The GOIRC-AIFA FARM6PMFJM trial 55
Totale 307
Categoria #
all - tutte 1.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.226


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202029 0 0 0 0 0 14 3 1 6 5 0 0
2020/202112 0 0 0 1 2 1 0 2 2 0 3 1
2021/202215 0 1 0 0 0 0 0 0 0 0 2 12
2022/202394 9 13 8 2 9 12 0 8 32 0 1 0
2023/202437 3 1 0 0 3 13 2 2 2 2 6 3
2024/202544 2 4 6 5 9 18 0 0 0 0 0 0
Totale 307